Changes to drug interaction alerts in medical software have been called for by medical professionals, who expressed concerns about the relevance and presentation of existing alerts.
An NPS survey, published in the Medical Journal of Australia, of 138 pharmacists and 191 GPs, identified a range of shortcomings in drug interaction alerts in software, calling for higher relevance of drug interaction alerts to practice; improved format and presentation of drug interaction alerts and differentiation of drug interaction alerts by severity.
Although the health professionals valued decision support for potential drug interactions, they wanted clearer guidance on the severity and clinical effects of drug interactions and management advice.
“GPs and pharmacists want drug interaction alert information to be relevant, useful, concise, and easy to...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.